Literature DB >> 7637263

Heme protein-induced tubular cytoresistance: expression at the plasma membrane level.

R A Zager1.   

Abstract

Following experimental rhabdomyolysis, animals become resistant to heme protein-induced acute renal failure (ARF). The goals of this study were to: (a) ascertain whether this resistance, previously documented only in vivo, is expressed directly at the proximal tubular cell level; (b) determine whether heme proteinuria (vs. other consequences of rhabdomyolysis) is its trigger; and (c) ascertain some of its subcellular determinants. Rats were injected with a borderline toxic dose of glycerol and 24 hours later proximal tubular segments (PTS) were isolated for study. Their vulnerability to diverse forms of injury (FeSO4-induced oxidant stress, hypoxia, Ca2+ ionophore, cytochalasin D, PLA2) was compared to that found in normal PTS. Post-glycerol PTS manifested significant resistance to each insult (decreased lactate dehydrogenase +/- N-acetyl-beta-D-glucosaminidase release). Protection against FeSO4 was virtually complete and it was associated with a 50% decrease in membrane lipid peroxidation. No decrease in hydroxyl radical generation was noted during the FeSO4 challenge (salicylate trap assessment), suggesting a primary increase in membrane resistance to attack. That PLA2 addition caused less deacylation, plasma membrane enzyme (alanine aminopeptidase) release, and LDH leakage from post-glycerol versus normal tubules supported this hypothesis. To test whether cytoresistance was specifically triggered by heme proteins (vs. being a non-specific filtered protein effect, or a result of endotoxin cascade activation), rats were injected with purified myoglobin, non-heme containing filterable proteins, or endotoxin. Only myoglobin induced cytoresistance. In vivo heme oxygenase inhibition (tin-protoporphyrin) did not block the emergence of cytoresistance and it was expressed despite Na,K-ATPase inhibition (ouabain) or cytoskeletal disruption (cytochalasin D). In vivo heat shock failed to protect. In conclusion, (1) rhabdomyolysis induces broad based proximal tubular cytoresistance; (2) heme proteinuria is its trigger; and (3) it is most easily explained by a primary increase in plasma membrane resistance to attack.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637263     DOI: 10.1038/ki.1995.189

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury.

Authors:  B A Vogt; T P Shanley; A Croatt; J Alam; K J Johnson; K A Nath
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Inorganic fluoride. Divergent effects on human proximal tubular cell viability.

Authors:  R A Zager; M Iwata
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.

Authors:  Richard A Zager
Journal:  Transl Res       Date:  2015-06-10       Impact factor: 7.012

4.  Renal cholesterol accumulation: a durable response after acute and subacute renal insults.

Authors:  R A Zager; T Andoh; W M Bennett
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

5.  The mevalonate pathway during acute tubular injury: selected determinants and consequences.

Authors:  Richard A Zager; Vallabh O Shah; Hemangini V Shah; Philip G Zager; Ali C M Johnson; Sherry Hanson
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Uremia induces proximal tubular cytoresistance and heme oxygenase-1 expression in the absence of acute kidney injury.

Authors:  Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-26

7.  Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance.

Authors:  M Iwata; J Herrington; R A Zager
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.